Lyell Immunopharma
LYEL
LYEL
106 hedge funds and large institutions have $180M invested in Lyell Immunopharma in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 22 reducing their positions, and 9 closing their positions.
Holders
106
Holders Change
+7
Holders Change %
+7.07%
% of All Funds
1.69%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
16
Increased
47
Reduced
22
Closed
9
Calls
$15K
Puts
$4K
Net Calls
+$11K
Net Calls Change
+$21K
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$1.1M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$10M |
| 3 |
3
TD Asset Management
Toronto,
Ontario, Canada
|
$1.35M |
| 4 |
4
BlackRock
New York
|
$19.7M |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$5.38M |
